Vanguard Group Inc Aim Immuno Tech Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AIM
# of Institutions
35Shares Held
4.09MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY698KShares$314,2490.0% of portfolio
-
Geode Capital Management, LLC Boston, MA352KShares$158,2450.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny221KShares$99,3630.0% of portfolio
-
State Street Corp Boston, MA173KShares$77,8960.0% of portfolio
-
Verition Fund Management LLC Greenwich, CT171KShares$76,9500.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $21.6M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...